The +Pec Proteomics Research Group (+PPRG) of the Institut d’Investigació Biomèdica de Lleida (IRBLleida), led by Dr. Gallart Palau and Dr. Serra, is looking for a postdoctoral researcher to work on the optimization and validation of a new drug delivery platform based on the use of extracellular vesicles, protected by European patent, for the targeted release of drugs within the Central Nervous System (CNS).
The contract will be linked within the framework of the “Validation of BP-EVs as a next-generation compound delivery platform for targeted release within the Central Nervous System” (EVBRAINTARGET) project prioritized by the IBEC under the “Plan Complementario de Biotecnología aplicada a la Salud” (biotechnology applied to health).
This Plan Complementario is co-financed by the Ministerio de Ciencia e Innovación and the Generalitat de Catalunya, with funds from the European Union NextGenerationEU (PRTR-C17.I1)
Deadline: 10 February 2023
For more details and access to the application form please click here.